259 related articles for article (PubMed ID: 26072728)
1. Secondary malignant neoplasms in testicular cancer survivors.
Curreri SA; Fung C; Beard CJ
Urol Oncol; 2015 Sep; 33(9):392-8. PubMed ID: 26072728
[TBL] [Abstract][Full Text] [Related]
2. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
3. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
[TBL] [Abstract][Full Text] [Related]
4. Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.
Groot HJ; Lubberts S; de Wit R; Witjes JA; Kerst JM; de Jong IJ; Groenewegen G; van den Eertwegh AJM; Poortmans PM; Klümpen HJ; van den Berg HA; Smilde TJ; Vanneste BGL; Aarts MJ; Incrocci L; van den Bergh ACM; Jóźwiak K; van den Belt-Dusebout AW; Horenblas S; Gietema JA; van Leeuwen FE; Schaapveld M
J Clin Oncol; 2018 Aug; 36(24):2504-2513. PubMed ID: 29989856
[TBL] [Abstract][Full Text] [Related]
5. Identification of risk factors and prediction models for secondary malignant neoplasms (SMNs)-free survival and SMNs-specific survival in testicular cancer survivors.
Fu H; Talluri S; Rai S; Liang L; Trivedi J; Ankem MK
World J Urol; 2023 Sep; 41(9):2413-2420. PubMed ID: 37530808
[TBL] [Abstract][Full Text] [Related]
6. Second malignant neoplasms after childhood non-central nervous system embryonal tumours in North America: A population-based study.
Zong X; Pole JD; Grundy PE; Mahmud SM; Parker L; Hung RJ
Eur J Cancer; 2017 Oct; 84():173-183. PubMed ID: 28822326
[TBL] [Abstract][Full Text] [Related]
7. Second malignant neoplasms in testicular cancer survivors.
Fung C; Fossa SD; Beard CJ; Travis LB
J Natl Compr Canc Netw; 2012 Apr; 10(4):545-56. PubMed ID: 22491051
[TBL] [Abstract][Full Text] [Related]
8. Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up.
Haugnes HS; Bosl GJ; Boer H; Gietema JA; Brydøy M; Oldenburg J; Dahl AA; Bremnes RM; Fosså SD
J Clin Oncol; 2012 Oct; 30(30):3752-63. PubMed ID: 23008318
[TBL] [Abstract][Full Text] [Related]
9. Treatment of testicular cancer and the development of secondary malignancies.
Bokemeyer C; Schmoll HJ
J Clin Oncol; 1995 Jan; 13(1):283-92. PubMed ID: 7799032
[TBL] [Abstract][Full Text] [Related]
10. Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment.
Rubino C; Adjadj E; Guérin S; Guibout C; Shamsaldin A; Dondon MG; Valteau-Couanet D; Hartmann O; Hawkins M; de Vathaire F
Int J Cancer; 2003 Dec; 107(5):791-6. PubMed ID: 14566829
[TBL] [Abstract][Full Text] [Related]
11. Secondary neoplasms following treatment of malignant germ cell tumors.
Bokemeyer C; Schmoll HJ
J Clin Oncol; 1993 Sep; 11(9):1703-9. PubMed ID: 8394879
[TBL] [Abstract][Full Text] [Related]
12. Risk of second malignant neoplasms among long-term survivors of testicular cancer.
Travis LB; Curtis RE; Storm H; Hall P; Holowaty E; Van Leeuwen FE; Kohler BA; Pukkala E; Lynch CF; Andersson M; Bergfeldt K; Clarke EA; Wiklund T; Stoter G; Gospodarowicz M; Sturgeon J; Fraumeni JF; Boice JD
J Natl Cancer Inst; 1997 Oct; 89(19):1429-39. PubMed ID: 9326912
[TBL] [Abstract][Full Text] [Related]
13. Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries.
Richiardi L; Scélo G; Boffetta P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Kee-Seng C; Jonasson JG; Martos C; Brennan P
Int J Cancer; 2007 Feb; 120(3):623-31. PubMed ID: 17096341
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
Lee JS; DuBois SG; Coccia PF; Bleyer A; Olin RL; Goldsby RE
Cancer; 2016 Jan; 122(1):116-23. PubMed ID: 26441212
[TBL] [Abstract][Full Text] [Related]
15. The graying of testis cancer patients: what have we learned?
Bajorin DF
J Clin Oncol; 2007 Oct; 25(28):4341-3. PubMed ID: 17906197
[No Abstract] [Full Text] [Related]
16. [Risk of secondary neoplasia after treatment of malignant germ cell tumors of the testis].
Bokemeyer C; Kuczyk MA; Köhne CH; Haupt A; Schmoll HJ
Med Klin (Munich); 1996 Nov; 91(11):703-10. PubMed ID: 9036294
[No Abstract] [Full Text] [Related]
17. Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study.
Henderson TO; Oeffinger KC; Whitton J; Leisenring W; Neglia J; Meadows A; Crotty C; Rubin DT; Diller L; Inskip P; Smith SA; Stovall M; Constine LS; Hammond S; Armstrong GT; Robison LL; Nathan PC
Ann Intern Med; 2012 Jun; 156(11):757-66, W-260. PubMed ID: 22665813
[TBL] [Abstract][Full Text] [Related]
18. Comparative mortality for 621 second cancers in 29356 testicular cancer survivors and 12420 matched first cancers.
Schairer C; Hisada M; Chen BE; Brown LM; Howard R; Fosså SD; Gail M; Travis LB
J Natl Cancer Inst; 2007 Aug; 99(16):1248-56. PubMed ID: 17686826
[TBL] [Abstract][Full Text] [Related]
19. Second malignant neoplasms: assessment and strategies for risk reduction.
Wood ME; Vogel V; Ng A; Foxhall L; Goodwin P; Travis LB
J Clin Oncol; 2012 Oct; 30(30):3734-45. PubMed ID: 23008293
[TBL] [Abstract][Full Text] [Related]
20. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE
Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
